Search

Search Constraints

You searched for: Author/Creator Schmeiser, Tim

Search Results

1. AB0215 A LATE ONSET OF SYSTEMIC SCLEROSIS IS ASSOCIATED WITH A MORE RAPIDLY PROGRESSING CLINICAL PHENOTYPE IN LCSSC PATIENTS. (June 2019)

2. Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Issue 7 (20th February 2018)

3. Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. Issue 10 (22nd July 2022)

4. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. Issue 2 (3rd November 2022)

5. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. (11th May 2017)

6. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. Issue 2 (2nd September 2020)

7. Older age onset of systemic sclerosis – accelerated disease progression in all disease subsets. (24th April 2020)

8. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. Issue 1 (21st January 2021)

10. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. (November 2022)